European Medicines Agency Watch [to 9 May 2015]

European Medicines Agency Watch [to 9 May 2015]

:: EMA tightens rules on ‘revolving door’ for committee members and experts
Intention to take up job in pharma industry will trigger immediate halt of involvement in medicines evaluation
The European Medicines Agency (EMA) has updated its rules on declarations of interests for scientific committee members and experts. The updates further strengthen EMA’s policy by restricting involvement of experts in the scientific assessment of medicines if they plan to take up a job in the pharmaceutical industry. The updates also include a revised guide on how to complete the Agency’s declaration of interest form…